Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9422
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKucuktasci, K.-
dc.contributor.authorSemiz, Serap-
dc.contributor.authorBalcı, Yasemin Işık-
dc.contributor.authorÖzsari, T.-
dc.contributor.authorGürses, Dolunay-
dc.contributor.authorÖnem, Gökhan-
dc.contributor.authorSaçar, Mustafa-
dc.date.accessioned2019-08-16T13:01:19Z
dc.date.available2019-08-16T13:01:19Z
dc.date.issued2016-
dc.identifier.issn1077-4114-
dc.identifier.urihttps://hdl.handle.net/11499/9422-
dc.identifier.urihttps://doi.org/10.1097/MPH.0000000000000634-
dc.description.abstractWolfram syndrome-1 is a rare and severe autosomal recessive neurodegenerative disease characterized by diabetes mellitus (DM), optic atrophy, diabetes insipidus, and deafness. Poorly controlled type 1 DM increases the risk for thrombosis. However, coexistence of DM and hereditary thrombosis factors is rarely observed. Here we present the case of a 13.5-year-old, nonfollowed girl newly diagnosed with poorly controlled Wolfram syndrome on the basis of the results of clinical and laboratory examinations. On the eighth day after diabetic ketoacidosis treatment, pulmonary embolism developed in the subject. Thrombus identified in the right atrium using echocardiography was treated by emergency thrombectomy. Homozygous mutation in the methylenetetrahydrofolate reductase gene C677T, heterozygous factor-V Leiden mutation, and active protein C resistance were identified in the patient. The patient was lost because of a recurring episode of pulmonary embolism on the 86th day of hospitalization. We present this case to highlight the need for investigating hereditary thrombosis risk factors in diabetic patients in whom thromboembolism develops. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherLippincott Williams and Wilkinsen_US
dc.relation.ispartofJournal of Pediatric Hematology/Oncologyen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectpulmonary embolismen_US
dc.subjectthrombofilia risk factorsen_US
dc.subjectWolfram syndromeen_US
dc.subjectblood clotting factor 5 Leidenen_US
dc.subjectC reactive proteinen_US
dc.subjectceftriaxoneen_US
dc.subjectdesmopressinen_US
dc.subjectenoxaparinen_US
dc.subjectheparinen_US
dc.subjectinsulinen_US
dc.subjectmethylenetetrahydrofolate reductase (NADPH2)en_US
dc.subjectprotein Cen_US
dc.subjectrheumatoid factoren_US
dc.subjectwarfarinen_US
dc.subjectblood clotting factor 5en_US
dc.subjectadolescenten_US
dc.subjectArticleen_US
dc.subjectcardiopulmonary arresten_US
dc.subjectcase reporten_US
dc.subjectclinical examinationen_US
dc.subjectcomputer assisted tomographyen_US
dc.subjectdegenerative diseaseen_US
dc.subjectdiabetes insipidusen_US
dc.subjectdiabetes mellitusen_US
dc.subjectdiabetic ketoacidosisen_US
dc.subjectechocardiographyen_US
dc.subjectembolismen_US
dc.subjectfemaleen_US
dc.subjectgeneen_US
dc.subjectgene mutationen_US
dc.subjectGlasgow coma scaleen_US
dc.subjecthearing impairmenten_US
dc.subjectheart atrium thrombosisen_US
dc.subjectheterozygosityen_US
dc.subjecthomozygosityen_US
dc.subjecthumanen_US
dc.subjectinsulin dependent diabetes mellitusen_US
dc.subjectlaboratory testen_US
dc.subjectloading drug doseen_US
dc.subjectlung embolismen_US
dc.subjectmethylenetetrahydrofolate reductase geneen_US
dc.subjectoptic nerve atrophyen_US
dc.subjectphysical examinationen_US
dc.subjectpriority journalen_US
dc.subjectresuscitationen_US
dc.subjectrisk factoren_US
dc.subjectsingle drug doseen_US
dc.subjectthrombectomyen_US
dc.subjectthromboembolismen_US
dc.subjectthrombophiliaen_US
dc.subjectthrombosisen_US
dc.subjectactivated protein C resistanceen_US
dc.subjectcomplicationen_US
dc.subjectfatalityen_US
dc.subjectgeneticsen_US
dc.subjectPulmonary Embolismen_US
dc.subjectActivated Protein C Resistanceen_US
dc.subjectAdolescenten_US
dc.subjectDiabetes Mellitus, Type 1en_US
dc.subjectFactor Ven_US
dc.subjectFatal Outcomeen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMethylenetetrahydrofolate Reductase (NADPH2)en_US
dc.subjectThrombophiliaen_US
dc.subjectWolfram Syndromeen_US
dc.titleFatal pulmonary embolism due to ınherited thrombophilia factors in a child with wolfram syndromeen_US
dc.typeArticleen_US
dc.relation.journalJournal of Pediatric Hematology/Oncologyen_US
dc.identifier.volume38en_US
dc.identifier.issue7en_US
dc.identifier.startpagee254en_US
dc.identifier.endpagee256en_US
dc.authorid0000-0003-0983-2834-
dc.identifier.doi10.1097/MPH.0000000000000634-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.pmid27379531en_US
dc.identifier.scopus2-s2.0-84977136884en_US
dc.identifier.wosWOS:000385523700010en_US
dc.identifier.scopusqualityQ2-
dc.ownerPamukkale University-
dc.snmzupdated-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.01. Surgical Medicine-
crisitem.author.dept14.01. Surgical Medicine-
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

38
checked on May 27, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.